Everolimus for the treatment of pancreatic neuroendocrine tumors

Author： Feldmann Georg   Bisht Savita   Schütte Ute   Haarmann Jens   Brossart Peter  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.14, 2012-10, pp. : 2073-2084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

By Bisht Savita   Feldmann Georg   Brossart Peter  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic neuroendocrine tumors in twelve baboons (Papio spp.)

By  

JOURNAL OF MEDICAL PRIMATOLOGY, Vol. 45, Iss. 2, 2016-04 ,pp. : 85-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging therapies for the treatment of patients with advanced neuroendocrine tumors

By Chan Jennifer A   Kulke Matthew H  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 253-270

Informa Healthcare

Access to resources Recommend Favorite

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: An ITMO group study

By Bajetta Emilio   Catena Laura   Fazio Nicola   Pusceddu Sara   Biondani Pamela   Blanco Giusi   Ricci Sergio   Aieta Michele   Pucci Francesca   Valente Monica   Bianco Nadia   Mauri Chiara Maria   Spada Francesca  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2457-2463

Blackwell Publishing

Access to resources Recommend Favorite

Neuroendocrine Tumors

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 7, 2009-07 ,pp. : 712-712

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite